Ares Systematic Credit »

Halozyme Therapeutics shares owned by Ares Systematic Credit

Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Ares Systematic Credit from 13F filings

Historical chart of Ares Systematic Credit investment in Halozyme Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Halozyme Therapeutics held by Ares Systematic Credit consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Halozyme Therapeutics by Ares Systematic Credit

Quarter filed Position value Share count Share price at filing
2026-06-30 $1.6M 1.4M 1.12
2025-12-31 $217k 200k 1.08